Welcure Drugs & Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
5.95 Cr.
|
P/BV
|
3.74
|
Book Value (Rs.)
|
1.18
|
52 Week High/Low (Rs.)
|
5/3
|
FV/ML
|
10/1
|
P/E(X)
|
58.67
|
Bookclosure
|
27/09/2023
|
EPS (Rs.)
|
0.08
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 0.08 | 0.02 | 0.05 | -0.01 | 0.00 |
Diluted EPS (Rs.) | 0.08 | 0.02 | 0.05 | -0.01 | 0.00 |
Cash EPS (Rs.) | 0.07 | 0.01 | 0.04 | -0.01 | 0.00 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 1.13 | 0.07 | 0.05 | 0.01 | 0.01 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 1.13 | 0.07 | 0.05 | 0.01 | 0.01 |
Revenue From Operations / Share (Rs.) | 0.00 | 0.08 | 0.10 | 0.06 | 0.06 |
PBDIT / Share (Rs.) | 0.07 | 0.01 | 0.04 | -0.01 | 0.00 |
PBIT / Share (Rs.) | 0.07 | 0.01 | 0.04 | -0.01 | 0.00 |
PBT / Share (Rs.) | 0.07 | 0.01 | 0.04 | -0.01 | 0.00 |
Net Profit / Share (Rs.) | 0.07 | 0.01 | 0.04 | -0.01 | 0.00 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 0.00 | 22.45 | 41.33 | -11.43 | 4.87 |
PBIT Margin (%) | 0.00 | 22.45 | 41.33 | -11.43 | 4.87 |
PBT Margin (%) | 0.00 | 22.45 | 41.33 | -11.43 | 4.87 |
Net Profit Margin (%) | 0.00 | 22.45 | 41.33 | -11.43 | 4.87 |
Return on Networth / Equity (%) | 6.71 | 25.35 | 79.39 | -66.06 | 16.35 |
Return on Capital Employeed (%) | 6.71 | 25.35 | 79.39 | -66.06 | 16.35 |
Return On Assets (%) | 6.65 | 24.35 | 75.47 | -38.34 | 13.00 |
Asset Turnover Ratio (%) | 0.00 | 1.24 | 2.73 | 3.03 | 2.99 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 0.43 | 17.30 | 20.28 | 2.38 | 4.88 |
Quick Ratio (X) | 0.43 | 17.30 | 20.28 | 2.38 | 4.88 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 5.40 | 11.77 | 2.23 | 0.48 | 0.63 |
EV / Net Operating Revenue (X) | 0.00 | 112.13 | 16.74 | 5.81 | 7.89 |
EV / EBITDA (X) | 51.47 | 499.33 | 40.49 | -50.84 | 161.76 |
MarketCap / Net Operating Revenue (X) | 0.00 | 112.76 | 17.09 | 5.88 | 8.08 |
Price / BV (X) | 3.57 | 128.55 | 32.98 | 36.36 | 27.89 |
Price / Net Operating Revenue (X) | 0.00 | 113.60 | 17.25 | 5.88 | 8.15 |
EarningsYield | 0.01 | 0.00 | 0.02 | -0.01 | 0.01 |